Development and reproducibility of a computed tomography-based measurement of renal sinus fat

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Foster, Meredith C ^a,b,c   Hwang, Shih Jen ^a,c   Porter, Stacy A ^d   Massaro, Joseph M ^e   Hoffmann, Udo ^f   Fox, Caroline S ^a,c,g  

^a FRAMINGHAM HEART STUDY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; FEMALE; HUMAN; INTRAABDOMINAL FAT; KIDNEY; KIDNEY SLICE; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY; RENAL SINUS FAT; REPRODUCIBILITY; VOLUMETRY; WAIST CIRCUMFERENCE; BODY FAT DISTRIBUTION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; FEASIBILITY STUDY; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; RADIOGRAPHY; STANDARD; STATISTICS; VALIDATION STUDY;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; BODY FAT DISTRIBUTION; FEASIBILITY STUDIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY; MALE; MIDDLE AGED; OBESITY; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053541014     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-52     Document Type: Article

References (43)

1. The burden of kidney disease: improving global outcomes. Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N, et al. Kidney Int 2004 66 1310 1314 10.1111/j.1523-1755.2004.00894.x 15458424 (Pubitemid 39302630)
2. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, et al. Kidney Int 2007 72 247 259 10.1038/sj.ki.5002343 17568785 (Pubitemid 47172384)
3. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
4. Chronic kidney disease and end-stage renal disease: a review produced to contribute to the report 'the status of health in the European Union: towards a healthier Europe. Zoccali C, Kramer A, Jager KJ, NDT Plus 2010 3 213 224 10.1093/ndtplus/sfp127
5. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
6. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. N Engl J Med 2004 351 1285 1295 10.1056/NEJMoa041365 15385655 (Pubitemid 39258422)
7. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. J Am Soc Nephrol 2004 15 1307 1315 10.1097/01.ASN.0000123691.46138.E2 15100371 (Pubitemid 38526012)
8. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D, Kidney Int 1999 56 2214 2219 10.1046/j.1523-1755.1999.00773.x 10594797 (Pubitemid 30004750)
9. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, et al. J Am Soc Nephrol 2002 13 1918 1927 10.1097/01.ASN.0000019641.41496.1E 12089389 (Pubitemid 34700618)
10. Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Wheeler DC, Townend JN, Landray MJ, Kidney Int Suppl 2003 201 S203
11. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, et al. Kidney Int 2007 71 159 166 10.1038/sj.ki.5002017 17136030 (Pubitemid 46094690)
12. Predictors of new-onset kidney disease in a community-based population. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D, JAMA 2004 291 844 850 10.1001/jama.291.7.844 14970063 (Pubitemid 38543772)
13. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S, Kidney Int 2004 65 1870 1876 10.1111/j.1523-1755.2004.00582.x 15086929 (Pubitemid 38591038)
14. Association between body mass index and CKD in apparently healthy men. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, et al. Am J Kidney Dis 2005 46 871 880 10.1053/j.ajkd.2005.08.015 16253727 (Pubitemid 41505461)
15. Body mass index and risk for end-stage renal disease. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS, Ann Intern Med 2006 144 21 28 16389251 (Pubitemid 46780716)
16. Overweight, Obesity, and the Development of Stage 3 CKD: The Framingham Heart Study. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, et al. Am J Kidney Dis 2008 52 39 48 10.1053/j.ajkd.2008.03.003 18440684 (Pubitemid 351853265)
17. Global burden of obesity in 2005 and projections to 2030. Kelly T, Yang W, Chen CS, Reynolds K, He J, Int J Obes (Lond) 2008 32 1431 1437 10.1038/ijo.2008.102
18. The epidemiology of obesity. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM, Gastroenterology 2007 132 2087 2102 10.1053/j.gastro.2007.03.052 17498505 (Pubitemid 46693751)
19. Prevalence of overweight and obesity in the United States, 1999-2004. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM, JAMA 2006 295 1549 1555 10.1001/jama.295.13.1549 16595758
20. The prevalence and costs of obesity in the EU. Fry J, Finley W, Proc Nutr Soc 2005 64 359 362 10.1079/PNS2005443 16048669 (Pubitemid 41160765)
21. The metabolic syndrome and chronic kidney disease in U.S. adults. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. Ann Intern Med 2004 140 167 174 14757614
22. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Kurella M, Lo JC, Chertow GM, J Am Soc Nephrol 2005 16 2134 2140 10.1681/ASN.2005010106 15901764 (Pubitemid 41716445)
23. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults. Lee JE, Choi SY, Huh W, Kim YG, Kim DJ, Oh HY, Am J Hypertens 2007 20 1189 1194 17954366 (Pubitemid 47588810)
24. Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, et al. Am J Kidney Dis 2008
25. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG, Int J Obes Relat Metab Disord 2004 28 Suppl 4 58 S65 15592488
26. Kidneys in infants and children: evaluation with MR. Dietrich RB, Kangarloo H, Radiology 1986 159 215 221 3952310 (Pubitemid 16112220)
27. Nuclear magnetic resonance imaging of the kidney. Hricak H, Crooks L, Sheldon P, Kaufman L, Radiology 1983 146 425 432 6849088 (Pubitemid 13225483)
28. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Chughtai HL, Morgan TM, Rocco M, Stacey B, Brinkley TE, Ding J, et al. Hypertension 2010 56 901 906 10.1161/HYPERTENSIONAHA.110.157370 20837881
29. Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Dwyer TM, Mizelle HL, Cockrell K, Buhner P, Int J Obes Relat Metab Disord 1995 19 869 874 8963354 (Pubitemid 26003023)
30. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Circulation 2007 116 39 48 10.1161/CIRCULATIONAHA.106.675355 17576866 (Pubitemid 47016245)
31. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U, Int J Obes (Lond) 2007 31 500 506 10.1038/sj.ijo. 0803454
32. The renal sinus: pathologic spectrum and multimodality imaging approach. Rha SE, Byun JY, Jung SE, Oh SN, Choi YJ, Lee A, et al. Radiographics 2004 24 Suppl 1 117 S131 15486236
33. Computed tomography and magnetic resonance imaging features of lesions of the renal medulla and sinus. Nikolaidis P, Gabriel H, Khong K, Brusco M, Hammond N, Yagmai V, et al. Curr Probl Diagn Radiol 2008 37 262 278 10.1067/j.cpradiol.2007.09.002 18823867
34. Intercapillary Lesions in the Glomeruli of the Kidney. Kimmelstiel P, Wilson C, Am J Pathol 1936 12 83 98 19970254
35. Intraglomerular lipid deposition in routine biopsies. Lee HS, Lee JS, Koh HI, Ko KW, Clin Nephrol 1991 36 67 75 1934662
36. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, et al. J Biol Chem 2005 280 32317 32325 10.1074/jbc.M500801200 16046411 (Pubitemid 41361841)
37. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Wang Z, Jiang T, Li J, Proctor G, McManaman JL, Lucia S, et al. Diabetes 2005 54 2328 2335 10.2337/diabetes.54.8.2328 16046298 (Pubitemid 41134259)
38. Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW, Am J Physiol Renal Physiol 2008 294 1315 F1322 10.1152/ajprenal.00550.2007 18417539
39. Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, et al. Am J Physiol Renal Physiol 2009 296 118 F126 18971213
40. Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, et al. Am J Physiol Regul Integr Comp Physiol 2009 297 803 R812 10.1152/ajpregu.00187. 2009 19605765
41. Abnormal kidney function as a cause and a consequence of obesity hypertension. Hall JE, Brands MW, Henegar JR, Shek EW, Clin Exp Pharmacol Physiol 1998 25 58 64 10.1111/j.1440-1681.1998.tb02146.x 9493561 (Pubitemid 28064510)
42. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Reisin E, Jack AV, Med Clin North Am 2009 93 733 751 10.1016/j.mcna.2009.02.010 19427502
43. MRI-determined fat content of human liver, pancreas and kidney. Sijens PE, Edens MA, Bakker SJ, Stolk RP, World J Gastroenterol 2010 16 1993 1998 10.3748/wjg.v16.i16.1993 20419836